Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial?
| Autor: | Jing-Yang Huang, Wen-Yuan Ku, Yu-Chun Tung, Oswald Ndi Nfor, Kai-Ming Jhang, Yung-Po Liaw, Zhi-Hong Jian |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty Ticlopidine medicine.medical_treatment Observational Study Internal medicine medicine Humans Carotid Stenosis Stroke Aged Proportional Hazards Models Retrospective Studies Aspirin business.industry Retrospective cohort study General Medicine medicine.disease Clopidogrel Surgery Regimen Carotid Arteries Platelet aggregation inhibitor Female Stents Carotid stenting business Platelet Aggregation Inhibitors medicine.drug Research Article Follow-Up Studies |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 0025-7974 |
| Popis: | The optimal antithrombotic regimen after carotid artery stenting (CAS) remains uncertain. We aimed to elucidate if long-term duration of aspirin plus clopidogrel after CAS would provide clinically relevant benefit. Patients receiving CAS were identified from the National Health Insurance Research Database, Taiwan. The discharge date following CAS was defined as index date. The study participants were divided into groups according to the prescribed duration of antiplatelet after the index date. They included the insufficient ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|